Drug for treating bone disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) C12Q 1/00 (2006.01) C12Q 1/02 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2200879

A useful remedy for bone diseases comprising .beta.-interferon which has the effect of relatively promoting osteogenesis without showing any calcification insufficiency as observed in the case of .gamma.-interferon. In particular, the preventive and therapeutic effects of .beta.-interferon have been proved as an increase in the bone mass in a model animal with bone diseases. Also, an interferon inducer is potentially usable as a remedy for bone diseases.

Cette invention concerne un remède contre les maladies osseuses, lequel comprend un .beta.-interféron qui pour effet de promouvoir relativement l'ostéogenèse, et sans pour autant présenter des insuffisances en ce qui concerne la calcification, comme c'est le cas avec le .gamma.-interféron. Les effets préventifs et thérapeutiques du .beta.-interféron ont été prouvés par l'augmentation de la masse osseuse chez un animal modèle atteint de maladies osseuses. Cette invention concerne également un inducteur d'interféron, lequel peut être potentiellement utilisé en qualité de remède contre les maladies osseuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Drug for treating bone disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug for treating bone disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for treating bone disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1992933

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.